Do BBH and BBP hold the same stocks?

By their latest filings, 20% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.

Which is more different from the S&P 500, BBH or BBP?

BBH has 64% of its weight in S&P 500 names and BBP has 10%, so BBH differs more from the index.

Which is cheaper, BBH or BBP?

BBH charges 0.35% a year and BBP charges 0.34%, so BBP is cheaper. Fees come from each fund's prospectus.

Data as of Nov 4, 2026.

Thematic ETFs

BBH vs BBP: Holdings Overlap & Returns

Share on X Download as PDF

Over the year to Nov 4, 2026, BBH returned +47.2% to BBP's +44.4%; 20% of their weight is in the same names.

askIQ about this page

askIQ about BBH and BBP

Net assets: $525m on Nov 3, 2026 for VanEck Biotech ETF, and $99m on Jul 31, 2026 for Virtus Biotech ETF.

BBH on its own →BBP on its own →

At a glance

64.4%

BBH in the S&P 500

10.5%

BBP in the S&P 500

+47.2%

BBH total return, 1 year

+44.4%

BBP total return, 1 year

BBH · 1 year to Nov 4, 2026 36% of its weight is outside the S&P 500

64% of BBH's weight is in S&P 500 companies and 36% is outside the index. Holdings as of Nov 2, 2026.

BBP · 1 year to Nov 4, 2026 90% of its weight is outside the S&P 500

11% of BBP's weight is in S&P 500 companies and 90% is outside the index. Holdings as of Jul 31, 2026.

Pair scorecard

BBP costs 0.01 points a year less; their one-year returns differ by 2.8 points.

BBH vs BBP: Holdings Overlap & Returns
Measure	BBH	BBP
Return
Measure	BBH	BBP
Total return, 1 year	+47.2%	+44.4%
Benchmark
Measure	BBH	BBP
What it tracks	Biotech	Biotech
Cost and size
Measure	BBH	BBP
Expense ratio	0.35%	0.34%
Net assets, BBH as of Nov 3, 2026 and BBP as of Jul 31, 2026	$525m	$99m
Holdings
Measure	BBH	BBP
Holdings in common	20%

Method

Risk and return

Dec 26, 2014 to Oct 30, 2026 · 618 weekly returns

BBH BBP

Return

Total return edge BBP +131.9% +304.2%

Annualized edge BBP +7.3% +12.5%

Price return edge BBP +121.3% +298.3%

Risk

Volatility edge BBH 22.7% 27.0%

Max drawdown edge BBH (slight) −37.7% −39.5%

Risk-adjusted

Sharpe edge BBP 0.33 0.49

Sortino edge BBP 0.48 0.74

Calmar edge BBP 0.19 0.32

Reading

From Dec 2014 to Oct 2026, BBP returned more: +304.2% to +131.9%. BBH swung less: 22.7% to 27.0%. BBH fell slightly less at its worst: −37.7% to −39.5%.

Full scorecard

9 measures, with how each is measured Open ↓

Risk and return: BBH vs BBP: Holdings Overlap & Returns
Measure	BBH	BBP	Edge	How it is measured
Return
Total return	+131.9%	+304.2%	BBP	Price change plus distributions, reinvested.
Annualized	+7.3%	+12.5%	BBP	Total return as a yearly rate.
Price return	+121.3%	+298.3%	BBP	Price change alone, distributions left out.
Risk
Volatility	22.7%	27.0%	BBH	Spread of weekly returns, annualized. Lower is steadier.
Downside deviation	15.7%	17.8%	BBH	Like volatility, counting only weeks below the Treasury bill rate.
Max drawdown	−37.7%	−39.5%	BBH (slight)	Deepest fall from a high to the low after it.
Risk-adjusted
Sharpe	0.33	0.49	BBP	Return above Treasury bills per unit of volatility.
Sortino	0.48	0.74	BBP	Return above Treasury bills per unit of downside deviation.
Calmar	0.19	0.32	BBP	Annualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 618 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

20%

By the books each fund has filed, BBH and BBP hold 20% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Nov 3, 2026.

50%

0 half 100%

half

20% in common

Positions both hold · largest shared weight first BBH BBP

Regeneron Pharmaceuticals Inc 7.99% 1.72%

Beone Medicines Ltd 2.56% 1.65%

Incyte Corp 2.07% 1.52%

Moderna Inc 6.88% 1.51%

Amgen Inc 16.53% 1.49%

Vertex Pharmaceuticals Inc 7.98% 1.48%

Neurocrine Biosciences Inc 1.55% 1.44%

Gilead Sciences Inc 14.17% 1.43%

Biogen Inc 2.88% 1.40%

Insmed Inc 1.85% 1.39%

Biontech Se 1.34% 1.38%

United Therapeutics Corp 2.38% 1.31%

Only in one fund ↓

Only in BBH

Natera Inc 4.44%

Iqvia Holdings Inc 4.18%

Argenx Se 4.13%

Revolution Medicines Inc 3.82%

Illumina Inc 3.37%

Guardant Health Inc 2.83%

Charles River Laboratories Internationa 1.71%

Icon Plc 1.43%

Only in BBP

CRINETICS PHARMACEUTICALS INC 3.34%

KINIKSA PHARMACEUTICALS INTERNATIONAL PLC 1.97%

VERASTEM INC 1.95%

PRECIGEN INC 1.94%

OMEROS CORP 1.87%

NUVATION BIO INC 1.77%

PROTAGONIST THERAPEUTICS INC 1.71%

ACADIA PHARMACEUTICALS INC 1.69%

Check overlap with more funds →

Window by window

Window by window: BBH vs BBP: Holdings Overlap & Returns
	Total return
Window	BBH	BBP
3 months	+24.3%	+8.8%
6 months	+38.3%	+16.6%
1 year	+47.2%	+44.4%
3 years	+75.4%	+113.7%
Since launchNot the same days: BBH Dec 2011 · BBP Dec 2014	+680.5%	+310.5%

Open this comparison in the app →

Side by side

BBH VanEck Biotech ETF · Holds 25 stocks in biotech, 64% of its weight in S&P 500 companies BBP Virtus Biotech ETF · Holds 67 stocks in biotech, 10% of its weight in S&P 500 companies

Issuer VanEck Virtus

Theme Biotech Biotech

In the S&P 500 64.4% 10.5%

Active share vs the S&P 500 99.0% 99.0%

In the Nasdaq-100 49.1% 7.1%

Holdings 25 67

Top ten, share of the fund 73.5% 19.6%

Expense ratio 0.35% 0.34%

Fee for the differing part 0.35% 0.34%

Total return, 1 year +47.2% +44.4%

vs its benchmark not measured not measured

Below its high 0.0% −4.1%

Net assets, BBH as of Nov 3, 2026 and BBP as of Jul 31, 2026 $525m $99m

As of Nov 4, 2026. Source: ETFIQ.

20% of the two portfolios are the same securities at the same weight.

Client brief:

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

About each fund

BBH

By weight, 64% of BBH's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 74% of the fund across 25 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +47.2% with distributions reinvested.

BBP

By weight, 10% of BBP's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 20% of the fund across 67 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +44.4% with distributions reinvested.

Questions people ask

Do BBH and BBP hold the same stocks?: By their latest filings, 20% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, BBH or BBP?: BBH has 64% of its weight in S&P 500 names and BBP has 10%, so BBH differs more from the index.
Which is cheaper, BBH or BBP?: BBH charges 0.35% a year and BBP charges 0.34%, so BBP is cheaper. Fees come from each fund's prospectus.

Other comparisons

BBH vs IBBQ BBH vs PBE BBH vs PBPH BBH vs FBT BBP vs IBBQ BBP vs FBT BBP vs IBB BBP vs PBE

Where to next

All thematic ETFs ranked by the S&P 500 Difference Score →How the scores are computed →BBH on its own →BBP on its own →BBH dividend history →BBH holdings →BBP holdings →Method →Standards and sources →

Sources and dates

BBH filings on SEC EDGAR ↗

BBH prospectus with the expense ratio (SEC) ↗

VanEck website ↗

BBP filings on SEC EDGAR ↗

BBP prospectus with the expense ratio (SEC) ↗

Virtus website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Every number is an ETFIQ calculation with distributions reinvested.

Cite this pageCitation, APA and Markdown

ETFIQ, BBH against BBP, data as of Nov 4, 2026. https://etfiq.com/compare/themes/bbh-vs-bbp

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.